Development Co‑operation Profiles: World Diabetes Foundation
Table of contents
The World Diabetes Foundation was established in 2002 by Novo Nordisk A/S. Since its creation, it has been active in more than 100 countries and has built partnerships with governments, civil society, the private sector, and international agencies. It is also engaged in regional and global advocacy.
With the vision to alleviate human suffering related to diabetes among those in greatest need, particularly in low- and middle-income countries, the World Diabetes Foundation aims to support sustainable, scalable and policy-based approaches, helping countries meet global targets for improved care of diabetes and other non-communicable diseases.
This profile presents verified data on development assistance allocation. See the Development Co-operation Profiles.
World Diabetes Foundation provided USD 20.1 million for development in 2023 through grantmaking activities. Compared to 2022, this amount represents an increase of 91.8% in real terms. Grants represented 100% of the World Diabetes Foundation’s gross disbursements.
In 2023, the World Diabetes Foundation channelled its bilateral development finance mainly through non-governmental organisations (NGOs) (USD 11.7 million) and multilateral organisations (USD 6.6 million).
In 2023, the World Diabetes Foundation provided USD 6.6 million to the multilateral system, representing 32.7% of its total development finance. All multilateral contributions were earmarked for specific countries, regions, themes or purposes. Nearly all (91.6%) were channelled through United Nations (UN) organisations.
The UN system received USD 6 million from the World Diabetes Foundation in 2023. The most significant UN recipients were the WHO - Core Voluntary Contributions Account (CVCA) (USD 5.5 million) and UNRWA (USD 500 thousand).
See the section on Geographic and thematic focus of ODA for the breakdown of bilateral allocations, including ODA earmarked through the multilateral development system.
In 2023, civil society organisations (CSOs) received USD 11.7 million of the World Diabetes Foundation’s gross bilateral finance, of which 16.6% was directed to developing country-based CSOs. More than half (57.8%) were earmarked to specific projects or programmes, while none were allocated to CSOs as core support. From 2022 to 2023, the combined core and earmarked contributions for CSOs decreased as a share of bilateral ODA, from 78.7% to 57.8%.
Learn more about the DAC Recommendation on Enabling Civil Society in Development Co-operation and Humanitarian Aid.
In 2023, the World Diabetes Foundation’s development finance was primarily focused on Africa and Asia (excluding the Middle East). USD 13.6 million was allocated to Africa and USD 4.7 million to Asia (excluding the Middle East), accounting for 67.5% and 23.5% of gross bilateral development finance, respectively.
In 2023, 56.1% of gross development finance went to the top 10 recipients, most notably Malawi, Mozambique and Cambodia.
Least developed countries (LDCs) received USD 8 million (39.7%) of the World Diabetes Foundation’s gross disbursements in 2023. World Diabetes Foundation allocated the highest share (39.7%) of its bilateral development finance to least developed countries in 2023, followed by upper middle-income countries (18.2%), noting that USD 8.5 million (42.1%) was unallocated by income group.
Furthermore, the World Diabetes Foundation allocated USD 4 million of its development finance to landlocked developing countries in 2023, and USD 1 million to small island developing states (SIDS) in 2023. The main SIDS recipients are Timor-Leste and the Marshall Islands.
Support to contexts with high and extreme fragility reached USD 8.5 million in 2023, representing 42% of the World Diabetes Foundation’s bilateral development finance.
Learn more about the OECD States of Fragility platform.
In 2023, the entirety of the World Diabetes Foundation’s bilateral contributions went to social infrastructure and services. Investments in this area amounted to USD 20.1 million.
In 2023, the World Diabetes Foundation committed all its contributions to SDG 3 (good health and well-being) of the United Nations 2030 Agenda.
Access the full list of providers at this link: Development Co-operation Profiles.
Official website: https://www.worlddiabetesfoundation.org
The methodological notes provide further details on the definitions and statistical methodologies applied, including the grant-equivalent methodology, core and earmarked contributions to multilateral organisations, country programmable aid, channels of delivery, bilateral ODA unspecified/unallocated, bilateral allocable ODA, the gender equality policy marker, and the environment markers.
This work is published under the responsibility of the Secretary-General of the OECD. The opinions expressed and arguments employed herein do not necessarily reflect the official views of the Member countries of the OECD.
This document, as well as any data and map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area.
© OECD 2025
Attribution 4.0 International (CC BY 4.0)
This work is made available under the Creative Commons Attribution 4.0 International licence. By using this work, you accept to be bound by the terms of this licence (https://creativecommons.org/licenses/by/4.0/).
Attribution – you must cite the work.
Translations – you must cite the original work, identify changes to the original and add the following text: In the event of any discrepancy between the original work and the translation, only the text of original work should be considered valid.
Adaptations – you must cite the original work and add the following text: This is an adaptation of an original work by the OECD. The opinions expressed and arguments employed in this adaptation should not be reported as representing the official views of the OECD or of its Member countries.
Third-party material – the licence does not apply to third-party material in the work. If using such material, you are responsible for obtaining permission from the third party and for any claims of infringement.
You must not use the OECD logo, visual identity or cover image without express permission or suggest the OECD endorses your use of the work.
Any dispute arising under this licence shall be settled by arbitration in accordance with the Permanent Court of Arbitration (PCA) Arbitration Rules 2012. The seat of arbitration shall be Paris (France). The number of arbitrators shall be one.
